Abstract | OBJECTIVE: DESIGN: A single-center, prospective, case-control trial. SETTING: PATIENTS: INTERVENTIONS: Twenty-four patients treated with NPPV by a facial mask strictly matched with 24 patients treated with invasive ventilation by endotracheal intubation. RESULTS: Use of NPPV avoided intubation in 67% of patients, and avoidance of intubation was associated with improved survival (100% vs. 38%; P=0.003). NPPV-treated patients required fewer invasive devices ( P<0.001) and had a lower incidence of pneumothoraces (8.3% vs. 37.5%; P=0.039). The NPPV-treated group required a nurse workload similar to that of the conventional ventilation group, but this group had a shorter duration of stay in the ICU ( P=0.013). The NPPV-treated group had a lower mortality in the ICU, the hospital and within 2 months of study entry. Differences in mortality between the two groups disappeared after 6 months. CONCLUSIONS: The findings of this study seem to provide further support for applying NPPV in AIDS patients with severe PCP-related ARF as a first-line therapeutic choice, but randomized controlled trials are required to confirm our results.
|
Authors | Marco Confalonieri, Edo Calderini, Susanna Terraciano, Giovanna Chidini, Enza Celeste, Giacomo Puccio, Cesare Gregoretti, G Umberto Meduri |
Journal | Intensive care medicine
(Intensive Care Med)
Vol. 28
Issue 9
Pg. 1233-8
(Sep 2002)
ISSN: 0342-4642 [Print] United States |
PMID | 12209270
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
|
Topics |
- AIDS-Related Opportunistic Infections
(complications, physiopathology, therapy)
- Acute Disease
- Adult
- Case-Control Studies
- Humans
- Intubation, Intratracheal
- Middle Aged
- Pneumonia, Pneumocystis
(complications, physiopathology, therapy)
- Prospective Studies
- Respiration, Artificial
(methods)
- Respiratory Insufficiency
(etiology, physiopathology, therapy)
- Survival Analysis
- Treatment Outcome
|